Actively Recruiting
ADHD&me: a Randomized Controlled Trial to Target Self-esteem in Youth With ADHD
Led by Universiteit Leiden · Updated on 2026-05-14
110
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
U
Universiteit Leiden
Lead Sponsor
L
Leids Universiteits Fonds
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to evaluate whether the ADHD&me (ADHD&ik) intervention can improve self-esteem in youth aged 16 to 25 years with Attention Deficit Hyperactivity Disorder (ADHD). ADHD is a neurodevelopmental disorder characterized by attention, impulsivity, and hyperactivity challenges, which often persist into adulthood and can impact many life areas. The study also investigates if the intervention affects related issues like masking ADHD behaviors and mental health symptoms such as anxiety, depression, and stress. The ADHD&me intervention is a cognitive behavioral therapy (CBT)-based program consisting of seven weekly individual sessions lasting 45 to 60 minutes each. Participants are randomly assigned to either an immediate treatment group or a waitlist control group that receives the intervention after an eight-week delay. The therapy includes exercises, goal setting, and homework assignments designed to improve self-esteem by addressing negative self-beliefs and coping behaviors related to ADHD. Participants complete questionnaires on self-esteem, ADHD symptoms, and mental health at baseline, post-treatment, and two-month follow-up. They also complete short daily assessments during one week at the start and after the intervention or waitlist period to capture momentary feelings and activities. Researchers monitor therapeutic quality and participant experiences throughout the study, with the primary outcome being self-esteem measured by the Rosenberg Self-Esteem Scale.
CONDITIONS
Brief Title
ADHD&me: Targeting Self-esteem in Youth With ADHD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 16 to 25 years.
- Official ADHD diagnosis confirmed by clinical interview.
- Low self-esteem confirmed by screening questionnaires and clinical assessment.
- ADHD medication allowed if dose stable for at least 4 weeks before baseline.
- Ability to participate in seven weekly individual therapy sessions.
You will not qualify if you...
- Severe depression or suicidal risk requiring immediate care.
- Receiving other psychological treatments during the study.
- Low self-esteem caused directly by trauma needing trauma-specific therapy.
- IQ below 80 based on specific cognitive tests.
- Severe substance use disorder.
- Confirmed or strongly suspected Autism Spectrum Disorder (ASD).
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 7 weeks
Participants receive the ADHD&me cognitive behavioral therapy intervention consisting of seven weekly individual sessions designed to improve self-esteem in emerging adults with ADHD.
7 weekly individual therapy sessions (in-person or remote)
Duration - 2 months
Participants complete follow-up assessments two months after the intervention to evaluate changes in self-esteem and related psychological outcomes.
1 follow-up assessment visit
Trial Site Locations
Total: 1 location
1
Psychologenpraktijk Kuin
Haarlem, Netherlands
Actively Recruiting
Research Team
B
Bianca Boyer
J
Jasmin Rahemenia
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here